Computed tomography assessment of exogenous surfactant-induced lung reaeration in patients with acute lung injury

Critical Care

Volumn 14, Issue 4, 2010, Pages

  Lu, Qin ^a   Zhang, Mao ^b   Girardi, Cassio ^c   Bouhemad, Belaïd ^a   Kesecioglu, Jozef ^d   Rouby, Jean Jacques ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HL 10; LUNG SURFACTANT; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG PARENCHYMA; LUNG VENTILATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL LUNG CAPACITY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; LUNG; LUNG GAS EXCHANGE; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; TREATMENT OUTCOME;

ACUTE LUNG INJURY; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78651241149     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9186     Document Type: Article

References (34)

1. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982, 70:673-683. 10.1172/JCI110662, 370271, 6896715.
2. Nakamura T, Malloy J, McCaig L, Yao LJ, Joseph M, Lewis J, Veldhuizen R. Mechanical ventilation of isolated septic rat lungs: effects on surfactant and inflammatory cytokines. J Appl Physiol 2001, 91:811-820.
3. Malloy JL, Veldhuizen RA, Lewis JF. Effects of ventilation on the surfactant system in sepsis-induced lung injury. J Appl Physiol 2000, 88:401-408.
4. Suresh GK, Soll RF. Overview of surfactant replacement trials. J Perinatol 2005, 25(Suppl 2):S40-44. 10.1038/sj.jp.7211320, 15861172.
5. Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, Jefferson LS, Conaway MR, Egan EA. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005, 293:470-476. 10.1001/jama.293.4.470, 15671432.
6. Spragg RG, Lewis JF, Wurst W, Hafner D, Baughman RP, Wewers MD, Marsh JJ. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 2003, 167:1562-1566. 10.1164/rccm.200207-782OC, 12649125.
7. Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996, 334:1417-1421. 10.1056/NEJM199605303342201, 8618579.
8. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004, 351:884-892. 10.1056/NEJMoa033181, 15329426.
9. Schmidt R, Markart P, Ruppert C, Wygrecka M, Kuchenbuch T, Walmrath D, Seeger W, Guenther A. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res 2007, 8:55. 10.1186/1465-9921-8-55, 1950506, 17662121.
10. Markart P, Ruppert C, Wygrecka M, Colaris T, Dahal B, Walmrath D, Harbach H, Wilhelm J, Seeger W, Schmidt R, Guenther A. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids. Thorax 2007, 62:588-594. 10.1136/thx.2006.062398, 2117258, 17287298.
11. Ainsworth SB, Beresford MW, Milligan DW, Shaw NJ, Matthews JN, Fenton AC, Ward Platt MP. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial. Lancet 2000, 355:1387-1392. 10.1016/S0140-6736(00)02136-X, 10791521.
12. Kesecioglu J, Beale R, Stewart TE, Findlay GP, Rouby JJ, Holzapfel L, Bruins P, Steenken EJ, Jeppesen OK, Lachmann B. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2009, 180:989-994. 10.1164/rccm.200812-1955OC, 19713451.
13. Rouby JJ, Constantin JM, Roberto De AGC, Zhang M, Lu Q. Mechanical ventilation in patients with acute respiratory distress syndrome. Anesthesiology 2004, 101:228-234. 10.1097/00000542-200407000-00033, 15220794.
14. Malbouisson LM, Busch CJ, Puybasset L, Lu Q, Cluzel P, Rouby JJ. Role of the heart in the loss of aeration characterizing lower lobes in acute respiratory distress syndrome. CT Scan ARDS Study Group. Am J Respir Crit Care Med 2000, 161:2005-2012.
15. Puybasset L, Cluzel P, Gusman P, Grenier P, Preteux F, Rouby JJ. Regional distribution of gas and tissue in acute respiratory distress syndrome. I. Consequences for lung morphology. CT Scan ARDS Study Group. Intensive Care Med 2000, 26:857-869. 10.1007/s001340051274, 10990099.
16. Nieszkowska A, Lu Q, Vieira S, Elman M, Fetita C, Rouby JJ. Incidence and regional distribution of lung overinflation during mechanical ventilation with positive end-expiratory pressure. Crit Care Med 2004, 32:1496-1503. 10.1097/01.CCM.0000130170.88512.07, 15241094.
17. Vieira SR, Puybasset L, Richecoeur J, Lu Q, Cluzel P, Gusman PB, Coriat P, Rouby JJ. A lung computed tomographic assessment of positive end-expiratory pressure-induced lung overdistension. Am J Respir Crit Care Med 1998, 158:1571-1577.
18. Malbouisson LM, Muller JC, Constantin JM, Lu Q, Puybasset L, Rouby JJ. Computed tomography assessment of positive end-expiratory pressure-induced alveolar recruitment in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163:1444-1450.
19. Reske AW, Busse H, Amato MB, Jaekel M, Kahn T, Schwarzkopf P, Schreiter D, Gottschaldt U, Seiwerts M. Image reconstruction affects computer tomographic assessment of lung hyperinflation. Intensive Care Med 2008, 34:2044-2053. 10.1007/s00134-008-1175-8, 18537024.
20. Malbouisson LM, Preteux F, Puybasset L, Grenier P, Coriat P, Rouby JJ. Validation of a software designed for computed tomographic (CT) measurement of lung water. Intensive Care Med 2001, 27:602-608. 10.1007/s001340100860, 11355132.
21. Lewis JF, McCaig L. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury. Am Rev Respir Dis 1993, 148:1187-1193.
22. Henry MD, Rebello CM, Ikegami M, Jobe AH, Langenback EG, Davis JM. Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs. Am J Respir Crit Care Med 1996, 154:366-375.
23. Davidson WJ, Dorscheid D, Spragg R, Schulzer M, Mak E, Ayas NT. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care 2006, 10:R41. 10.1186/cc4851, 1550886, 16542488.
24. Torresin M, Zimmermann LJ, Cogo PE, Cavicchioli P, Badon T, Giordano G, Zacchello F, Sauer PJ, Carnielli VP. Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes. Am J Respir Crit Care Med 2000, 161:1584-1589.
25. Grotberg JB, Halpern D, Jensen OE. Interaction of exogenous and endogenous surfactant: spreading-rate effects. J Appl Physiol 1995, 78:750-756.
26. Sandiford P, Province MA, Schuster DP. Distribution of regional density and vascular permeability in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995, 151:737-742.
27. Hafner D, Germann PG. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant. J Pharmacol Toxicol Methods 1999, 41:97-106. 10.1016/S1056-8719(99)00025-8, 10598681.
28. Stamme C, Brasch F, von Bethmann A, Uhlig S. Effect of surfactant on ventilation-induced mediator release in isolated perfused mouse lungs. Pulm Pharmacol Ther 2002, 15:455-461. 10.1006/pupt.2002.0383, 12406668.
29. Strohmaier W, Trupka A, Pfeiler C, Thurnher M, Khakpour Z, Gippner-Steppert C, Jochum M, Redl H. Bilateral lavage with diluted surfactant improves lung function after unilateral lung contusion in pigs. Crit Care Med 2005, 33:2286-2293. 10.1097/01.CCM.0000182819.11807.16, 16215383.
30. van Putte BP, Cobelens PM, van der Kaaij N, Lachmann B, Kavelaars A, Heijnen CJ, Kesecioglu J. Exogenous surfactant attenuation of ischemia-reperfusion injury in the lung through alteration of inflammatory and apoptotic factors. J Thorac Cardiovasc Surg 2009, 137:824-828. 10.1016/j.jtcvs.2008.08.046, 19327503.
31. Wemhoner A, Rudiger M, Gortner L. Inflammatory cytokine mRNA in monocytes is modified by a recombinant (SP-C)-based surfactant and porcine surfactant. Methods Find Exp Clin Pharmacol 2009, 31:317-323. 10.1358/mf.2009.31.5.1386592, 19649338.
32. Erpenbeck VJ, Fischer I, Wiese K, Schaumann F, Schmiedl A, Nassenstein C, Krug N, Hohlfeld JM. Therapeutic surfactants modulate the viability of eosinophils and induce inflammatory mediator release. Int Arch Allergy Immunol 2009, 149:333-342. 10.1159/000205579, 19295237.
33. Kesecioglu J, Schultz MJ, Maas JJ, De Wilde RB, Steenken EI, Lachmann B. Treatment of acute lung injury and ARDS with surfactant is safe [abstract]. Am J Respir Crit Care Med 2004, 169:A349.
34. Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley MA, Cai GZ, Hite RD, Smith RM, Hudson LD, Crim C, Newton P, Mitchell BR, Gold AJ. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997, 155:1309-1315.